Skip to Content

Harrys A. Torres, M.D., F.A.C.P., F.I.D.S.A.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, Term Tenure, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1400 Pressler
Unit Number: 1460
Houston, TX 77030
Room Number: FCT12.6084
Fax: 713.745.6839

Education & Training

Degree-Granting Education

2009 The University of Texas, Health Science Center at Houston, Houston, TX, Residency, Internal Medicine
2007 The University of Texas, Health Science Center at Houston, M. D. Anderson Cancer Center, Houston, TX, Diplomate, Infectious Diseases
2007 The University of Texas, Health Science Center at Houston, Thomas Street Clinic-Harris County Hospital District, Houston, TX, Specialist, HIV/AIDS Medicine
1999 Universidad Central de Venezuela, Caracas, Venezuela, Diplomate, Infectious Diseases
1997 Venezuelan Institute of Social Security, Caracas, Venezuela, Residency, Internal Medicine
1995 Universidad de Oriente, School of Medicine, Barcelona, Venezuela, Medical degree, Medicine

Postgraduate Training

7/2007-6/2009 Clinical Residency, Internal Medicine, The University of Texas, Health Science Center at Houston, Houston, TX
7/2006-6/2007 Clinical Fellowship, HIV/AIDS Medicine, The University of Texas, Health Science Center at Houston-Thomas St. Clinic-Harris County Hospital, Houston, TX
7/2005-6/2007 Clinical Fellowship, Infectious Diseases, The University of Texas, Health Science Center at Houston-M.D. Anderson Cancer Center, Houston, TX
2/2000-6/2005 Research Fellowship, Infectious Complications in Immunocompromised Patients with Cancer or Bone Marrow Transplant Recipients, The University of Texas MD Anderson Cancer Center, Houston, TX
12/1997-12/1999 Clinical Fellowship, Infectious Diseases, University Hospital of Caracas, Universidad Central de Venezuela, Caracas, Venezuela
12/1995-12/1997 Clinical Residency, Internal Medicine, Dr. José G. Hernández Hospital, Venezuelan Institute of Social Security, Caracas, Venezuela

Board Certifications

2012 Completed American Society of Tropical Medicine and Hygiene, CTropMed® program 2012
10/2010 American Board of Internal Medicine, Infectious Diseases
8/2009 American Board of Internal Medicine


Institutional Committee Activities

Member, Comprehensive Cancer Control Liver Workshop, 2012-present
Member, Clinical Effectiveness Subcommittee, 2012-2016
Member, Clinical Research Committee, 2011-2012
Member, Infection Control, 2009-2012

Selected Publications

Peer-Reviewed Original Research Articles

1. Mahale P, Sturgis EM, Tweardy DJ, Ariza-Heredia EJ, Torres HA. Association between Hepatitis C Virus and Head and Neck cancers. Journal of the National Cancer Institute. In Press.
2. Jain P, Verstovsek S, Wang W, Loghavi S, Torres HA, Estrov Z, Patel KP, Pemmaraju N. DNMT3A, TET2 and JAK2 mutations in polycythemia vera following long- term remission of secondary acute myeloid leukemia. Leukemia and Lymphoma. In Press.
3. Kyvernitakis A, Mahale P, Popat UR, Jiang Y, Hosry J, Champlin RE, Torres HA. Hepatitis C virus infection in patients undergoing hematopoietic cell transplantation in the era of direct-acting antiviral agents. Biology of Blood and Marrow Transplantation. In Press.
4. Mahale P, Thomas SK, Kyvernitakis A, Torres HA. Management of multiple myeloma complicated by hepatitis C virus reactivation - the role of new antiviral therapy. Forum Infectious Diseases. In Press.
5. Varma A, Saliba RM, Torres HA, Afrough A, Hosing C, Khouri IF, Nieto Y, Shah ND, Parmar S, Bashir Q, Ahmed S, Jones RB, Kebriaei P, Olson A, Shpall EJ, Alousi AM, Qazilbash MH, Champlin RE, Popat UR. Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation. Bone Marrow Transplantation. In Press.
6. Mahale P, Turturro F, Romaguera JE, Fowler N, Torres HA. The Effect of Different Rituximab-Containing Chemotherapy Strategies on Hepatitis C Viremia. Leukemia and Lymphoma, 11/2015. PMID: 26402559.
7. Torres HA, Mahale P. Most patients with HCV-associated lymphoma present with mild liver disease: A call to revise antiviral treatment prioritization. Liver Int 35(6):1661-4, 2015.
8. Hassan MM, Abdel-Wahab R, Kaseb A, Phan AT, El-Serag HB, Morris J, Singh Raghav KP, Lee JS, Vauthey JN, Shalaby A, Torres HA, Amos CI, Li D. Significant Impact of Early Adulthood Obesity on Risk and Prognosis of Hepatocellular Carcinoma in the United States. Gastroenterology 149(1):119-29, 2015.
9. Torres HA, Mahale P, Miller ED, Oo TH, Frenette C, Kaseb AO. Coadministration of Telaprevir and Transcatheter Arterial Chemoembolization in the Management of Hepatitis C Virus-Associated Hepatocellular Carcinoma. World J Hepatol 5(6):332-5, 2013.
10. Georgiadou SP, Lewis RE, Best L, Torres HA, Champlin R, Kontoyiannis DP. The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis. Bone Marrow Transplant 48(1):141-3, 2013.
11. Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Lewis R, Hwang J, Davila M, Torres HA. Acute exacerbation and viral reactivation of chronic hepatitis C infection in cancer patients. Journal of Hepatology 57(6):1177-85, 2012.
12. Chemaly RF, Torres HA, Munsell MF, Shah DP, Rathod DB, Bodey GP, Hosing C, Saifan C, Raad II, Champlin RE. An Adaptive Randomized Trial of Intermittent Dosing Schedule of Aerosolized Ribavirin in Cancer Patients with Respiratory Syncytial Virus Infections. Journal of Infectious Diseases 54(3):218-22, 2012.
13. Torres HA, Adachi JA, Roach LR, Smith KM, Mahale P, Davila M, Raad II. Hepatitis C Clinic operated by Infectious Disease at a Comprehensive Cancer Center – Help is on the way. Clinical Infectious Diseases 54(5):740-742, 2012.
14. Torres HA, Nevah MI, Barnett BJ, Mahale P, Kontoyiannis DP, Hassan MM, Raad II. Hepatitis C Virus Genotype Distribution Varies by Underlying Disease Status among Patients in the Same Geographic Region: A Retrospective Multicenter Study. J Clin Virol. 54(3):218-22, 2012.
15. Mahale P, Kaseb AO, Davila M, Torres HA. The Effect of Transcatheter Arterial Chemoembolization on Hepatitis C viremia. Oncologist 17(9):21-3, 2012.
16. Aisenberg GM, Torres HA, Tarrand J, Safdar A, Bodey GP, Chemaly RF. Herpes Simplex Virus Lower Respiratory Tract Infection in Patients with Solid Tumors. Cancer 115(1):199-206, 2009.
17. Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad II. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. Cancer 112(6):1282-7, 2008.
18. Torres HA, Aguilera EA, Safdar A, Rohatgi N, Raad II, Sepulveda C, Luna M, Kontoyiannis DP, Chemaly RF. Fatal cytomegalovirus pneumonia in patients with haematological malignancies: an autopsy-based case–control study. Clinical Microbiology and Infection 14:1160–6, 2008.
19. Chemaly RF, Torres HA, Hachem R, Kontoyiannis DP, Safdar A, Raad II. Human Herpesvirus-6 DNAemia in Immunosuppressed Adult Patients with Leukemia at risk for mold infection. Haematologica 93(1):157-8, 2008.
20. Raad II, Hanna HA, Boktour M, Jiang Y, Torres HA, Afif C, Kontoyiannis DP, Hachem RY. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia 22:496–503, 2008.
21. Torres HA, Barnett B, Arduino RC. Alopecia associated to ritonavir-boosted atazanavir therapy. AIDS 21(10):1391-1392, 2007.
22. Torres HA, Aguilera EA, Mattiuzzi G, Cabanillas M, Rohatgi N, Sepulveda C, Kantarjian HH, Safdar A, Raad II, Chemaly RF. Characteristics and Outcome of Respiratory syncytial virus infection in patients with leukemia. Haematologica 92:1216-1223, 2007.
23. Arias CA, Torres HA, Singh KV, Panesso D, Moore J, Wagner A, Murray BE. Failure of daptomycin monotherapy in the treatment of endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster. Clin Infect Dis 45:1343–6, 2007.
24. Chemaly RF, Torres HA, Aguilera EA, Mattiuzzi G, Cabanillas M, Kantarjian H, Gonzalez V, Safdar A, Raad II. Neuraminidase Inhibitors Improve Outcome of Patients with Leukemia and Influenza Infection: An Observational Study. Clin Infect Dis 44:964-7, 2007.
25. Torres HA, Bull L, Arduino RC. Tongue Hyperpigmentation in a Caucasian Patient Coinfected With HIV and Hepatitis C During Peginterferon Alfa-2b and Ribavirin Therapy. Am J Gastroenterol 102(6):1334-1335, 2007.
26. Torres HA, Barnett B, Arduino RC. Use of fosamprenavir, a sulfa-containing protease inhibitor, in HIV-infected patients with glucose-6-phosphate dehydrogenase deficiency. Clin Infect Dis 44(6):887-8, 2007.
27. Torres HA, Hanna HA, Graviss L, Chaiban G, Hachem R, Chemaly RF, Girgawy E, Raad II. Chest Tube related multidrug-resistant Staphylococcus aureus empyema: Could the chest tube be coated with antiseptics? Infect Control Hosp Epidemiol 27(2):195-7, 2006.
28. Torres HA, Kontoyiannis DP, Aguilera EA, Younes A, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma 6(5):393-8, 2006.
29. Torres HA, Chemaly RF, Storey R, Aguilera EA, Nogueras GM, Safdar A, Rolston KVI, Raad II, Kontoyiannis DP. Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients. Eur J Clin Microbiol Infect Dis 5(6):382-8, 2006.
30. Chemaly RF, Torres HA, Hachem RY, Nogueras GM, Aguilera EA, Younes A, Luna MA, Rodriguez G, Tarrand JJ, Raad II. Cytomegalovirus Pneumonia in Patients with Lymphoma. Cancer 104(6):1213-1220, 2005.
31. Torres HA, Kontoyiannis DP, Bodey GP, Adachi JA, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Gastrointestinal Cytomegalovirus Disease In Patients With Cancer. European Journal of Cancer 41(15):2268-2279, 2005.
32. Lionakis MS, Lewis RE, Torres HA, Albert ND, Raad II, Kontoyiannis DP. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn Microbiol Infect Dis 52(1):15-20, 2005.
33. Kontoyiannis DP, Boktour M, Hanna H, Torres HA, Hachem R, Raad II. Itraconazole Added to a Lipid Formulation of Amphotericin B Does Not Improve Outcome of Primary Treatment of Invasive Aspergillosis. Cancer 103(11):2334-7, 2005.
34. Torres HA, Prieto VG, Raad II, Reddy BT, Kontoyiannis DP. Proven pulmonary cryptococcosis due to capsule-deficient Cryptococcus neoformans does not differ clinically from proven pulmonary cryptococcosis due to capsule-intact C. neoformans. Mycoses 48:21-24, 2005.
35. Torres HA, Kontoyiannis DP, Rolston KVI. High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study. Support Care Cancer 12(7):511-6, 2004.
36. Steinbach WJ, Benjamin DK Jr, Kontoyiannis DP, Perfect JR, Lutsar I, Marr KA, Lionakis MS, Torres HA, Jafri H, Walsh TJ. Infections Due to Aspergillus terreus: A Multicenter Retrospective Analysis of 83 Cases. Clin Infect Dis 39(2):192–8, 2004.
37. Kontoyiannis DP, Torres HA, Chagua M, Hachem R, Tarrand JJ, Bodey GP, Raad II. Trichosporonosis in a Tertiary Care Cancer Center: Risk Factors, Changing Spectrum and Determinants of Outcome. Scand J Infect Dis 36(8):564-569, 2004.
38. Torres HA, Rivero GA, Lewis RE, Raad II, Kontoyiannis DP. Aspergillosis caused by non-fumigatus Aspergillus species: Risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagn Microbiol Infect Dis 46:25-28, 2003.
39. Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand J, Han XY, Rolston KVI, Safdar A, Raad II, Kontoyiannis DP. Candidemia in a Tertiary Care Cancer Center: In Vitro Susceptibility and its Correlation with Outcome of Initial Antifungal Therapy. Medicine (Baltimore) 82:309-21, 2003.
40. Kontoyiannis DP, Hachem R, Lewis RE, Rivero GA, Torres HA, Thornby J, Champlin R, Kantarjian H, Bodey GP, Raad II. Efficacy and toxicity of the caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of pulmonary aspergillosis in patients with hematologic malignancies. Cancer 98(2):292-9, 2003.
41. Torres HA, Bodey GP, Rolston KVI, Kantarjian HM, Raad II, Kontoyiannis DP. Infections in Patients with Aplastic Anemia: Experience at a Tertiary Care Cancer Center. Cancer 98(1):86-93, 2003.
42. Rivero GA, Torres HA, Rolston KVI, Kontoyiannis DP. Listeria monocytogenes infection in patients with cancer. Diagn Microbiol Infect Dis 47:393-8, 2003.
43. Torres HA, Bodey GP, Tarrand JJ, Kontoyiannis DP. Protothecosis in Patients with Cancer: cases series and literature review. Clinical Microbiology and Infection 9:786-92, 2003.
44. Reddy BT, Torres HA, Kontoyiannis DP. Breast Implant Infection Caused by Trichosporon Beigelii. Scand J Infect Dis. 34(2):143-4, 2002.
45. Torres HA, Rivero GA, Kontoyiannis DP. Endemic Mycoses in a Cancer Hospital. Medicine (Baltimore) 81(3):201-12, 2002.
46. Torres HA, Reddy BT, Raad II, Tarrand J, Bodey GP, Hanna HA, Rolston KVI, Kontoyiannis DP. Nocardiosis in Patients with Cancer. Medicine (Baltimore) 81(5):388-97, 2002.
47. Shaikh ZH, Torres HA, Walsh GL, Champlin RE, Kontoyiannis DP. Open Lung Biopsy in Bone Marrow Transplant Recipients Has a Poor Diagnostic Yield for a Specific Diagnosis. Transpl Infect Dis 4(2):80-4, 2002.
48. Kontoyiannis DP, Reddy BT, Torres HA, Luna M, Lewis RE, Tarrand J, Bodey GP, Raad II. Pulmonary candidiasis in patients with cancer: an autopsy study. Clin Infect Dis 34(3):400-3, 2002.

Last updated: 1/28/2016